Multi Cancer Early Detection Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Gene Panel, LDT & Others), By End-use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 4 Business Days
Multi Cancer Early Detection Market Growth & Trends
The global multi cancer early detection market size is expected to reach USD 2.77 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 15.80% from 2022 to 2030. The need for providing effective ways to detect cancer at an early stage so that the right treatment can be given and the rising prevalence of cancer and multiple forms are expected to fuel the growth of the market. The requirement for early detection diagnostics, which facilitates simple disease management and subsequently lowers the death rate, drives the overall market.
Multi cancer early detection (MCED) tests are designed to find tumors in the body even when a patient is asymptomatic. To determine whether there is a high probability that a person has cancer, they simultaneously evaluate several signals. Although numerous tests are being developed to detect cancer at an early stage, the first MCED screening test was just recently made available in the U.S. as a lab-developed test. For instance, in July 2022, GRAIL’s Galleri was made available as an LDT at Mercy, St. Louis. Furthermore, MCED screening tests are being developed by Exact Sciences and Freenome, and GRAIL's Galleri test is being marketed without payer coverage with the claim that it can detect up to fifty different forms.
Studies show that MCED tests have a higher sensitivity for detecting later-stage or advanced than for detecting earlier stages, which are more treatable and occasionally curable. Additionally, it was found that the tests were highly specific, which made it extremely unlikely that they would give a positive result for someone who did not have cancer. To meet the demand for early diagnosis, ongoing research is still being done in the field of developing MCED.
The major players in the market assert that they can identify as few as two or three different cancer types or as many as fifty. They are focusing on the growth and development of these screening tests and faster commercialization. For instance, in December 2020, Singlera Genomics raised $150 million in Series B funding for the development, marketing, and promotion of its MCED tests. GRAIL launched a pilot project with Point32Health, making Point32Health the first commercial plan for health to include MCED tests.
Multi Cancer Early Detection Market Report Highlights
Multi Cancer Early Detection Market Growth & Trends
The global multi cancer early detection market size is expected to reach USD 2.77 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 15.80% from 2022 to 2030. The need for providing effective ways to detect cancer at an early stage so that the right treatment can be given and the rising prevalence of cancer and multiple forms are expected to fuel the growth of the market. The requirement for early detection diagnostics, which facilitates simple disease management and subsequently lowers the death rate, drives the overall market.
Multi cancer early detection (MCED) tests are designed to find tumors in the body even when a patient is asymptomatic. To determine whether there is a high probability that a person has cancer, they simultaneously evaluate several signals. Although numerous tests are being developed to detect cancer at an early stage, the first MCED screening test was just recently made available in the U.S. as a lab-developed test. For instance, in July 2022, GRAIL’s Galleri was made available as an LDT at Mercy, St. Louis. Furthermore, MCED screening tests are being developed by Exact Sciences and Freenome, and GRAIL's Galleri test is being marketed without payer coverage with the claim that it can detect up to fifty different forms.
Studies show that MCED tests have a higher sensitivity for detecting later-stage or advanced than for detecting earlier stages, which are more treatable and occasionally curable. Additionally, it was found that the tests were highly specific, which made it extremely unlikely that they would give a positive result for someone who did not have cancer. To meet the demand for early diagnosis, ongoing research is still being done in the field of developing MCED.
The major players in the market assert that they can identify as few as two or three different cancer types or as many as fifty. They are focusing on the growth and development of these screening tests and faster commercialization. For instance, in December 2020, Singlera Genomics raised $150 million in Series B funding for the development, marketing, and promotion of its MCED tests. GRAIL launched a pilot project with Point32Health, making Point32Health the first commercial plan for health to include MCED tests.
Multi Cancer Early Detection Market Report Highlights
- By type, the liquid biopsy segment is expected to emerge as the fastest-growing segment over the forecast period owing to it being the most emerging technique for detecting DNA-based blood test
- By end-use, the hospitals segment held the largest revenue share in 2021 due to the presence of specialized healthcare professionals focusing on improving the treatment with early detection
- North America is anticipated to be the fastest-growing region over the forecast period owing to the high prevalence of cancer among the population in the region, with cancer being the 2nd most common cause of death
CHAPTER 1 MULTI CANCER EARLY DETECTION MARKET: METHODOLOGY AND SCOPE
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis (model 2)
1.6.2.1 Approach 2: Volume price analysis
1.6.2.2 Revenue modeling
1.7 List of Secondary Sources
1.8 List of Primary Sources
CHAPTER 2 MULTI CANCER EARLY DETECTION MARKET: EXECUTIVE SUMMARY
2.1 Market summary
CHAPTER 3 MULTI CANCER EARLY DETECTION MARKET: INDUSTRY OUTLOOK
3.1. Market Lineage outlook
3.1.1. Related/ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Analysis
3.4. User Perspective Analysis
3.4.1. Consumer Behavior Analysis
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.1.1. Increasing prevalence of cancer
3.5.1.2 Extensive R&D for the development of MCED
3.5.1.3 Need to develop diagnostic options that can detect cancer at an early stage
3.5.2. Market Restraint Analysis
3.5.2.1. Collection of adequate safety and efficacy data for regulatory approval
3.5.3. Industry Challenges
3.5.4. Opportunity Analysis
3.6. Multi Cancer Early Detection: Market Analysis Tools
3.6.1. Industry Analysis - Porter’s Five Forces
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat from new entrant
3.6.1.5. Competitive rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political Landscape
3.6.2.2. Environmental Landscape
3.6.2.3. Social Landscape
3.6.2.4. Technology Landscape
3.6.2.5. Legal Landscape
CHAPTER 4 MULTI CANCER EARLY DETECTION MARKET: COMPETITIVE LANDSCAPE
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Ansoff Matrix
4.2 Major Deals & Strategic Alliances Analysis
4.2.1 Joint Ventures
4.2.2 Licensing and Partnerships
4.2.3 Technological Collaborations
4.3 Company/Competition Categorization
4.4 Vendor Landscape
4.4.1 List of Key Distributors and Channel Partners
4.4.2 Key Customers
4.5 Public Companies
4.5.1 Company Market Position Analysis
4.6 Private Companies
4.6.1 List of Key Emerging Companies
4.6.2 Regional Network Map
CHAPTER 6 MULTI CANCER EARLY DETECTION MARKET: TYPE BUSINESS ANALYSIS
5.1 Definition and Scope
5.2 Type Market Share Analysis, 2021 & 2030
5.3 Global Multi Cancer Early Detection Market, By Type, 2018 To 2030
5.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1 Liquid Biopsy
5.4.1.1 Liquid Biopsy Market, 2018 - 2030 (USD Million)
5.4.2 Gene Panel, LDT,& Others
5.4.2.1 Gene Panel, LDT,& Others Market, 2018 - 2030 (USD Million)
CHAPTER 6 MULTI CANCER EARLY DETECTION MARKET: END-USE BUSINESS ANALYSIS
6.1 Definition and Scope
6.2 End-Use Market Share Analysis, 2021 & 2030
6.3 Global Multi Cancer Early Detection Market, By End-use, 2018 To 2030
6.4 Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.4.1 Hospitals
6.4.1.1 Hospitals Market, 2018 - 2030 (USD Million)
6.4.2 Diagnostic Laboratories
6.4.2.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
6.4.3 Others
6.4.3.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 7 MULTI CANCER EARLY DETECTION MARKET: REGIONAL BUSINESS ANALYSIS
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 MEA
7.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
7.7 North America
7.7.1 North America Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.7.2 U.S.
7.7.2.1 U.S. Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.7.3 Canada
7.7.3.1 Canada Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8 Europe
7.8.1 Europe Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.2 U.K.
7.8.2.1 U.K. Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.3 Germany
7.8.3.1 Germany Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.4 France
7.8.4.1 France Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.5 Italy
7.8.5.1 Italy Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.6 Spain
7.8.6.1 Spain Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.9 Asia Pacific
7.9.1 Asia Pacific Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.9.2 Japan
7.9.2.1 Japan Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.9.3 China
7.9.3.1 China Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.9.4 India
7.9.4.1 India Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.4 Australia
7.8.4.1 Australia Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.5 South Korea
7.8.5.1 South Korea Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.10 Latin America
7.10.1 Latin America Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.10.2 Brazil
7.10.2.1 Brazil Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.10.3 Mexico
7.10.3.1 Mexico Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.3 Argentina
7.8.3.1 Argentina Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.11 MEA
7.11.1 MEA Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.11.2 South Africa
7.11.2.1 South Africa Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.12.2 Saudi Arabia
7.12.2.1 Saudi Arabia Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.13.3 UAE
7.13.3.1 UAE Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
CHAPTER 8 MULTI CANCER EARLY DETECTION MARKET: COMPANY PROFILING
8.1 Company Profiles
8.1.1. Grail, LLC
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2. Illumina, Inc.
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3. Exact Sciences Corporation.
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4. Foundation Medicine, Inc.
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5. AnchorDx
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6. Guardant Health, Inc.
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7. Burning Rock Biotech Limited
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 GENECAST
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 Laboratory for Advanced Medicine, Inc.
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Singlera Genomics Inc.
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
8.2 List of Other Key Players
8.2.1. Freenome Holdings, Inc.
8.2.2 Elypta AB
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates and forecast timeline
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis
1.6.1.1 Approach 1: Commodity flow approach
1.6.2 Volume price analysis (model 2)
1.6.2.1 Approach 2: Volume price analysis
1.6.2.2 Revenue modeling
1.7 List of Secondary Sources
1.8 List of Primary Sources
CHAPTER 2 MULTI CANCER EARLY DETECTION MARKET: EXECUTIVE SUMMARY
2.1 Market summary
CHAPTER 3 MULTI CANCER EARLY DETECTION MARKET: INDUSTRY OUTLOOK
3.1. Market Lineage outlook
3.1.1. Related/ancillary Market Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Analysis
3.4. User Perspective Analysis
3.4.1. Consumer Behavior Analysis
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.1.1. Increasing prevalence of cancer
3.5.1.2 Extensive R&D for the development of MCED
3.5.1.3 Need to develop diagnostic options that can detect cancer at an early stage
3.5.2. Market Restraint Analysis
3.5.2.1. Collection of adequate safety and efficacy data for regulatory approval
3.5.3. Industry Challenges
3.5.4. Opportunity Analysis
3.6. Multi Cancer Early Detection: Market Analysis Tools
3.6.1. Industry Analysis - Porter’s Five Forces
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat from new entrant
3.6.1.5. Competitive rivalry
3.6.2. PESTEL Analysis
3.6.2.1. Political Landscape
3.6.2.2. Environmental Landscape
3.6.2.3. Social Landscape
3.6.2.4. Technology Landscape
3.6.2.5. Legal Landscape
CHAPTER 4 MULTI CANCER EARLY DETECTION MARKET: COMPETITIVE LANDSCAPE
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.1.1 Ansoff Matrix
4.2 Major Deals & Strategic Alliances Analysis
4.2.1 Joint Ventures
4.2.2 Licensing and Partnerships
4.2.3 Technological Collaborations
4.3 Company/Competition Categorization
4.4 Vendor Landscape
4.4.1 List of Key Distributors and Channel Partners
4.4.2 Key Customers
4.5 Public Companies
4.5.1 Company Market Position Analysis
4.6 Private Companies
4.6.1 List of Key Emerging Companies
4.6.2 Regional Network Map
CHAPTER 6 MULTI CANCER EARLY DETECTION MARKET: TYPE BUSINESS ANALYSIS
5.1 Definition and Scope
5.2 Type Market Share Analysis, 2021 & 2030
5.3 Global Multi Cancer Early Detection Market, By Type, 2018 To 2030
5.4 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.4.1 Liquid Biopsy
5.4.1.1 Liquid Biopsy Market, 2018 - 2030 (USD Million)
5.4.2 Gene Panel, LDT,& Others
5.4.2.1 Gene Panel, LDT,& Others Market, 2018 - 2030 (USD Million)
CHAPTER 6 MULTI CANCER EARLY DETECTION MARKET: END-USE BUSINESS ANALYSIS
6.1 Definition and Scope
6.2 End-Use Market Share Analysis, 2021 & 2030
6.3 Global Multi Cancer Early Detection Market, By End-use, 2018 To 2030
6.4 Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.4.1 Hospitals
6.4.1.1 Hospitals Market, 2018 - 2030 (USD Million)
6.4.2 Diagnostic Laboratories
6.4.2.1 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
6.4.3 Others
6.4.3.1 Others Market, 2018 - 2030 (USD Million)
CHAPTER 7 MULTI CANCER EARLY DETECTION MARKET: REGIONAL BUSINESS ANALYSIS
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2021 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 SWOT Analysis, By Factor (Political & Legal, Economic And Technological)
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 MEA
7.6 Market Size, & Forecasts, Trend Analysis, 2021 to 2030
7.7 North America
7.7.1 North America Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.7.2 U.S.
7.7.2.1 U.S. Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.7.3 Canada
7.7.3.1 Canada Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8 Europe
7.8.1 Europe Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.2 U.K.
7.8.2.1 U.K. Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.3 Germany
7.8.3.1 Germany Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.4 France
7.8.4.1 France Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.5 Italy
7.8.5.1 Italy Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.6 Spain
7.8.6.1 Spain Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.9 Asia Pacific
7.9.1 Asia Pacific Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.9.2 Japan
7.9.2.1 Japan Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.9.3 China
7.9.3.1 China Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.9.4 India
7.9.4.1 India Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.4 Australia
7.8.4.1 Australia Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.5 South Korea
7.8.5.1 South Korea Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.10 Latin America
7.10.1 Latin America Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.10.2 Brazil
7.10.2.1 Brazil Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.10.3 Mexico
7.10.3.1 Mexico Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.8.3 Argentina
7.8.3.1 Argentina Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.11 MEA
7.11.1 MEA Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.11.2 South Africa
7.11.2.1 South Africa Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.12.2 Saudi Arabia
7.12.2.1 Saudi Arabia Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
7.13.3 UAE
7.13.3.1 UAE Multi Cancer Early Detection Market, 2018 - 2030 (USD Million)
CHAPTER 8 MULTI CANCER EARLY DETECTION MARKET: COMPANY PROFILING
8.1 Company Profiles
8.1.1. Grail, LLC
8.1.1.1 Company overview
8.1.1.2 Financial performance
8.1.1.3 Product benchmarking
8.1.1.4 Strategic initiatives
8.1.2. Illumina, Inc.
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic initiatives
8.1.3. Exact Sciences Corporation.
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic initiatives
8.1.4. Foundation Medicine, Inc.
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5. AnchorDx
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic initiatives
8.1.6. Guardant Health, Inc.
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7. Burning Rock Biotech Limited
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 GENECAST
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 Laboratory for Advanced Medicine, Inc.
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Singlera Genomics Inc.
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
8.2 List of Other Key Players
8.2.1. Freenome Holdings, Inc.
8.2.2 Elypta AB
LIST OF TABLES
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global Multi Cancer Early Detection Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 6 Global Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 7 North America Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 9 North America Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 10 U.S. Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 11 U.S. Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 12 Canada Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 13 Canada Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 14 Europe Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 15 Europe Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 16 Europe Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 17 U.K. Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 18 U.K. Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 19 Germany Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 20 Germany Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 21 France Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 22 France Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 23 Spain Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 24 Spain Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 25 Italy Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 26 Italy Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 30 China Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 31 China Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 32 Japan Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 33 Japan Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 34 India Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 35 India Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 36 South Korea Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 37 South Korea Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 38 Australia Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 39 Australia Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 40 Latin America Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 41 Latin America Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 42 Latin America Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 43 Brazil Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 44 Brazil Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 45 Brazil Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 46 Mexico Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 47 Mexico Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 48 Argentina Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 49 Argentina Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 50 MEA Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 51 MEA Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 52 MEA Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 53 South Africa Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 54 South Africa Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 55 Saudi Arabia Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 57 UAE Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 58 UAE Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Regulatory Framework
Table 4 Global Multi Cancer Early Detection Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 6 Global Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 7 North America Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 8 North America Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 9 North America Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 10 U.S. Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 11 U.S. Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 12 Canada Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 13 Canada Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 14 Europe Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 15 Europe Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 16 Europe Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 17 U.K. Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 18 U.K. Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 19 Germany Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 20 Germany Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 21 France Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 22 France Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 23 Spain Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 24 Spain Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 25 Italy Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 26 Italy Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 29 Asia Pacific Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 30 China Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 31 China Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 32 Japan Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 33 Japan Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 34 India Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 35 India Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 36 South Korea Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 37 South Korea Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 38 Australia Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 39 Australia Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 40 Latin America Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 41 Latin America Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 42 Latin America Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 43 Brazil Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 44 Brazil Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 45 Brazil Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 46 Mexico Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 47 Mexico Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 48 Argentina Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 49 Argentina Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 50 MEA Multi Cancer Early Detection Market, By Country, 2018 - 2030 (USD Million)
Table 51 MEA Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 52 MEA Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 53 South Africa Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 54 South Africa Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 55 Saudi Arabia Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 56 Saudi Arabia Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
Table 57 UAE Multi Cancer Early Detection Market, By Type, 2018 - 2030 (USD Million)
Table 58 UAE Multi Cancer Early Detection Market, By End-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain - Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Multi Cancer Early Detection Market Segmentation
FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 11 Penetration & Growth Prospect Mapping
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Market Penetration & Growth Prospect Mapping
FIG. 15 Multi Cancer Early Detection Market: Type Movement Analysis
FIG. 16 Liquid biopsy Market, 2018 - 2030 (USD Million)
FIG. 17 Gene Panel, LDT, & Others Market, 2018 - 2030 (USD Million)
FIG. 18 Multi Cancer Early Detection Market: End-use Movement Analysis
FIG. 19 Hospitals Market, 2018 - 2030 (USD Million)
FIG. 20 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
FIG. 21 Others Market, 2018 - 2030 (USD Million)
FIG. 22 Regional Marketplace: Key Takeaways
FIG. 23 Regional Outlook, 2018 & 2030
FIG. 24 Regional Market Dashboard
FIG. 25 Regional Market Place: Key Takeaways
FIG. 26 North America, SWOT Analysis
FIG. 27 Europe, SWOT Analysis
FIG. 28 Asia Pacific, SWOT Analysis
FIG. 29 Latin America, SWOT Analysis
FIG. 30 MEA, SWOT Analysis
FIG. 31 North America
FIG. 32 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 33 U.S.
FIG. 34 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 35 Canada
FIG. 36 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 37 Europe
FIG. 38 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 39 U.K.
FIG. 40 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 41 Germany
FIG. 42 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 43 France
FIG. 44 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 45 Italy
FIG. 46 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 47 Spain
FIG. 48 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 49 Asia Pacific
FIG. 50 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 51 Japan
FIG. 52 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 53 China
FIG. 54 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 55 India
FIG. 56 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 57 Australia
FIG. 58 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 59 South Korea
FIG. 60 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 61 Latin America
FIG. 62 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 63 Brazil
FIG. 64 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 65 Mexico
FIG. 66 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 67 Argentina
FIG. 68 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 69 MEA
FIG. 70 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 71 South Africa
FIG. 72 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 73 Saudi Arabia
FIG. 74 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 75 UAE
FIG. 76 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 77 Strategy Mapping
FIG. 1 Market Research Process
FIG. 2 Information Procurement
FIG. 3 Primary Research Pattern
FIG. 4 Market Research Approaches
FIG. 5 Value Chain - Based Sizing & Forecasting
FIG. 6 Market Formulation & Validation
FIG. 7 Multi Cancer Early Detection Market Segmentation
FIG. 8 Market Driver Relevance Analysis (Current & Future Impact)
FIG. 9 Market Restraint Relevance Analysis (Current & Future Impact)
FIG. 10 Market Challenge Relevance Analysis (Current & Future Impact)
FIG. 11 Penetration & Growth Prospect Mapping
FIG. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
FIG. 13 Porter’s Five Forces Analysis
FIG. 14 Market Penetration & Growth Prospect Mapping
FIG. 15 Multi Cancer Early Detection Market: Type Movement Analysis
FIG. 16 Liquid biopsy Market, 2018 - 2030 (USD Million)
FIG. 17 Gene Panel, LDT, & Others Market, 2018 - 2030 (USD Million)
FIG. 18 Multi Cancer Early Detection Market: End-use Movement Analysis
FIG. 19 Hospitals Market, 2018 - 2030 (USD Million)
FIG. 20 Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
FIG. 21 Others Market, 2018 - 2030 (USD Million)
FIG. 22 Regional Marketplace: Key Takeaways
FIG. 23 Regional Outlook, 2018 & 2030
FIG. 24 Regional Market Dashboard
FIG. 25 Regional Market Place: Key Takeaways
FIG. 26 North America, SWOT Analysis
FIG. 27 Europe, SWOT Analysis
FIG. 28 Asia Pacific, SWOT Analysis
FIG. 29 Latin America, SWOT Analysis
FIG. 30 MEA, SWOT Analysis
FIG. 31 North America
FIG. 32 North America Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 33 U.S.
FIG. 34 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 35 Canada
FIG. 36 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 37 Europe
FIG. 38 Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 39 U.K.
FIG. 40 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 41 Germany
FIG. 42 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 43 France
FIG. 44 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 45 Italy
FIG. 46 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 47 Spain
FIG. 48 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 49 Asia Pacific
FIG. 50 Asia Pacific Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 51 Japan
FIG. 52 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 53 China
FIG. 54 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 55 India
FIG. 56 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 57 Australia
FIG. 58 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 59 South Korea
FIG. 60 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 61 Latin America
FIG. 62 Latin America Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 63 Brazil
FIG. 64 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 65 Mexico
FIG. 66 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 67 Argentina
FIG. 68 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 69 MEA
FIG. 70 MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 71 South Africa
FIG. 72 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 73 Saudi Arabia
FIG. 74 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 75 UAE
FIG. 76 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
FIG. 77 Strategy Mapping
